Video
17 Mar 2025
Eversyn: For broader use of bioactive sugars for nutrition and biopharma | MPI Magdeburg [ENG]
Eversyn, a Start-up venture of the MPI Magdeburg, owns the novel technology for the inexpensive and highly scalable synthesis of nucleotide sugars and oligosaccharides.
https://www.eversyn.de/
Content provided by our supplier
Eversyn GmbH
-
DE -
2025On CPHI since
-
1 - 24Employees
Company types
Primary activities
Other Content from Eversyn GmbH ()
Recently Visited
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance